AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GANCICLOVIR
6 registrations across 5 African markets— 5 active
Markets with GANCICLOVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| GLOVIRAX Gel | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD | active | Jul 2029 |
| VIRGAN Gel ophtalmique / 1.5 mg/gr | 🇹🇳Tunisia | THEA | expired | Dec 1997 |
| CYMEVENE LYOPHILISAT POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| VIRGAN GEL OPHTALMIQUE | 🇲🇦Morocco | — | active | — |
| VIRGAN gel ophtalmique / 1,5 mg / g | 🇸🇳Senegal | THEA | active | — |
| GANVIR 0,15 % GEL OPHTALMIQUE, FLACON DE 10 G | 🇨🇮Côte d'Ivoire | ORCHIDIA PHARMACEUTICAL IND | active | — |
GANCICLOVIR in Africa — Regulatory Overview
GANCICLOVIR is registered across 5 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Côte d'Ivoire, Kenya, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 5 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.